Search results
Results from the WOW.Com Content Network
This is the list of Schedule V controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
Schedule 5 (S5) drugs and poisons are substances and preparations that must have appropriate packaging and simple warning labels to display that these poisons: have low toxicity or a low concentration; have a low to moderate hazard; can cause only minor adverse effects to the human being in normal use; require caution in handling, storage, or use.
The tables below contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses.
In Portugal, temazepam is a Schedule IV controlled drug under Decree-Law 15/93. [91] In Slovenia, it is regulated as a Group II (Schedule 2) controlled substance under the Production and Trade in Illicit Drugs Act. [84] In South Africa, temazepam is a Schedule 5 drug, requiring a special prescription, and is restricted to 10– to 30-mg doses. [92]
Schedule 5 or Schedule V may refer to: Schedule V Controlled Substances within the US Controlled Substances Act List of Schedule V drugs (US) Schedule V Controlled Drugs and Substances within the Canadian Controlled Drugs and Substances Act; Scheduled Areas in India, from the Fifth Schedule of the Constitution of India
Methaqualone is a hypnotic sedative.It was sold under the brand names Quaalude (/ ˈ k w eɪ l uː d / KWAY-lood) and Sopor among others, which contained 300 mg of methaqualone, and sold as a combination drug under the brand name Mandrax, which contained 250 mg methaqualone and 25 mg diphenhydramine within the same tablet, mostly in Europe.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
The DEA rescheduled buprenorphine from a schedule V drug to a schedule III drug just before approval. [99] The ACSCN for buprenorphine is 9064, and being a schedule III substance, it does not have an annual manufacturing quota imposed by the DEA. [100] The salt in use is the hydrochloride, which has a free-base conversion ratio of 0.928.